ASO Visual Abstract: Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial.

Qihan FuYiwen ChenDabing HuangChengxiang GuoXiaochen ZhangWenbo XiaoXing XueQi ZhangXiang LiShunliang GaoRisheng QueYan ShenJian WuMin ZhangTingbo LiangTingbo Liang

Published in: Annals of surgical oncology (2023)

Keyphrases

phase ii
open label
phase iii
clinical trial
placebo controlled
double blind
squamous cell carcinoma
locally advanced
small cell lung cancer
study protocol
radiation therapy